Quick Answer
AbbVie Inc. reported Stockholders Equity of -$3.27 billion for the year ending 2025.
- AbbVie Inc. showed a decrease of -198.3% in Stockholders Equity from 2024 to 2025.
- This data is from AbbVie Inc.'s annual report (Form 10-K), filed with the SEC on February 20, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $2.96 billion | Q2 2013: $3.56 billion | Q3 2013: $3.58 billion | Q1 2014: $4.70 billion | Q2 2014: $5.22 billion | Q3 2014: $4.65 billion | Q1 2015: $1.38 billion | Q2 2015: $5.50 billion | Q3 2015: $4.86 billion | Q1 2016: $4.64 billion | Q2 2016: $5.64 billion | Q3 2016: $6.47 billion | Q1 2017: $5.00 billion | Q2 2017: $6.01 billion | Q3 2017: $6.69 billion | Q1 2018: $3.55 billion | Q2 2018: -$3.38 billion | Q3 2018: -$2.92 billion | Q4 2018: -$8.45 billion | Q1 2019: -$7.83 billion | Q2 2019: -$8.57 billion | Q3 2019: -$8.23 billion | Q1 2020: -$7.42 billion | Q2 2020: $14.71 billion | Q3 2020: $15.27 billion | Q1 2021: $13.71 billion | Q2 2021: $12.57 billion | Q3 2021: $13.55 billion | Q1 2022: $16.28 billion | Q2 2022: $14.65 billion | Q3 2022: $15.99 billion | Q1 2023: $13.27 billion | Q2 2023: $12.87 billion | Q3 2023: $12.09 billion | Q1 2024: $8.01 billion | Q2 2024: $6.78 billion | Q3 2024: $6.03 billion | Q1 2025: $1.42 billion | Q2 2025: -$183.00 million | Q3 2025: -$2.64 billion.
- Over the full 14 years of available data (2012 to 2025), AbbVie Inc.'s Stockholders Equity has declined by 834.3%.
- Historical annual values: Fiscal year 2025: -$3.27 billion | Fiscal year 2024: $3.33 billion | Fiscal year 2023: $10.36 billion | Fiscal year 2022: $17.25 billion | Fiscal year 2021: $15.41 billion | Fiscal year 2020: $13.08 billion | Fiscal year 2019: -$8.17 billion | Fiscal year 2018: -$8.45 billion | Fiscal year 2017: $5.10 billion | Fiscal year 2016: $4.64 billion | Fiscal year 2015: $3.95 billion | Fiscal year 2014: $1.74 billion | Fiscal year 2013: $4.49 billion | Fiscal year 2012: -$350.00 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: